Home/Filings/4/0001444380-25-000032
4//SEC Filing

Christoforou Christofer 4

Accession 0001444380-25-000032

CIK 0001444380other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:29 PM ET

Size

9.1 KB

Accession

0001444380-25-000032

Insider Transaction Report

Form 4
Period: 2025-02-28
Christoforou Christofer
SVP, Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-02-28+530137,610 total
  • Tax Payment

    Common Stock

    2025-02-28$5.72/sh642$3,672136,655 total
  • Tax Payment

    Common Stock

    2025-03-02$5.72/sh800$4,576135,855 total
  • Tax Payment

    Common Stock

    2025-02-28$5.72/sh313$1,790137,297 total
Footnotes (2)
  • [F1]Represents Performance Stock Units ("PSUs") initially granted on February 28, 2022 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the second milestone vesting condition upon which a portion of the PSUs vested.
  • [F2]Includes 104,032 restricted stock units.

Issuer

NEVRO CORP

CIK 0001444380

Entity typeother

Related Parties

1
  • filerCIK 0001681047

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:29 PM ET
Size
9.1 KB